425: Core Scientific Amends Merger Disclosures Amid Lawsuits

Core Scientific provides supplemental disclosures for its merger with CoreWeave to address shareholder lawsuits challenging proxy statement information.

Summary

• Core Scientific, Inc. entered into an Agreement and Plan of Merger with CoreWeave, Inc. and Miami Merger Sub I, Inc. on July 7, 2025, for Core Scientific to become a wholly owned subsidiary of CoreWeave.
• A registration statement on Form S-4 was filed on August 20, 2025, amended on September 17, 2025, and September 25, 2025, and declared effective by the SEC on September 26, 2025.
• Core Scientific mailed a definitive proxy statement/prospectus to stockholders on or about September 26, 2025.
• Three lawsuits (Barcia et al. vs. Booth et al., Kaufmann vs. Core Scientific, Inc. et al., Williams vs. Core Scientific, Inc. et al.) and several demand letters were filed by purported stockholders alleging disclosure deficiencies in the proxy statement/prospectus.
• Core Scientific and CoreWeave voluntarily supplemented the proxy statement/prospectus with additional disclosures to moot disclosure claims and avoid nuisance, potential expense, and delay, while denying the necessity or materiality of such disclosures.
• Supplemental disclosures include updated estimated aggregate value of unvested Core Scientific RSU Awards for non-employee directors, totaling $8,515,576.
• Updated tables for Selected Publicly Traded Companies Analysis for Core Scientific and CoreWeave were provided, including TEV and TEV/Adj. EBITDA/EBIT multiples.
• The Discounted Cash Flow Analysis for Core Scientific and CoreWeave was amended, detailing the calculation methodology, terminal value assumptions (e.g., 18.0x to 22.0x exit multiple for Core Scientific's Colocation Pipeline Business terminal year Adjusted EBITDA of $899 million), and discount rate ranges (e.g., 10.00% to 12.00% for CoreWeave).

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the existence of lawsuits is a negative, the company's proactive step to provide supplemental disclosures to address these claims and move the merger forward is a positive sign of management's commitment to the transaction and shareholder communication.

Positives

• Core Scientific and CoreWeave are proactively addressing shareholder concerns by providing supplemental disclosures, aiming to resolve litigation and proceed with the merger.
• The companies are moving forward with the merger process, having achieved SEC effectiveness for the Form S-4 and mailed the proxy statement/prospectus.

Negatives

• Multiple lawsuits and demand letters have been filed by purported stockholders alleging disclosure deficiencies in the merger proxy statement/prospectus.
• The existence of litigation introduces uncertainty and potential for expense and delay in the merger process.

Risks

• Completion of the proposed transaction on anticipated terms or at all, and the timing thereof, including obtaining Core Scientific stockholder approval.
• Uncertainty in the value of consideration Core Scientific stockholders would receive due to fluctuations in CoreWeave common stock market price.
• Potential litigation relating to the proposed transaction that could be instituted against Core Scientific, CoreWeave, or their respective directors and officers.
• Disruptions from the proposed transaction harming Core Scientific's or CoreWeave's business, including current plans and operations, and diversion of management's time and attention.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Development delays at Core Scientific and/or CoreWeave's data center sites, including conversion from crypto mining to high-performance computing.
• Core Scientific's ability to earn digital assets profitably and attract customers for high-density colocation capabilities.
• Price volatility of digital assets and Bitcoin in particular.
• Potential changes in interpretive positions of the SEC or its staff with respect to digital asset mining firms.
• The possibility that the transaction may be more expensive to complete than anticipated.

Future Outlook

The future outlook is centered on the successful consummation of the proposed merger with CoreWeave and the realization of anticipated benefits, including synergies and value creation. However, this is subject to significant risks such as obtaining stockholder approval, potential litigation, integration challenges, market price fluctuations of CoreWeave common stock, and broader economic and regulatory changes affecting the artificial intelligence, data center, and crypto mining industries. The ability to successfully convert crypto mining facilities to high-performance computing sites and manage power resources are also key forward-looking considerations.

Management Comments

• All of the defendants believe that the Matters are without merit.
• Core Scientific and CoreWeave believe that the disclosures set forth in the proxy statement/prospectus comply fully with applicable law.
• To moot disclosure claims and to avoid nuisance, potential expense and delay, Core Scientific and CoreWeave have determined to voluntarily supplement the proxy statement/prospectus with the below disclosures.
• Core Scientific and CoreWeave deny all allegations in the Matters that any additional disclosure was or is required.

Industry Context

This announcement reflects a significant strategic move within the digital infrastructure sector, where traditional cryptocurrency mining companies like Core Scientific are increasingly pivoting towards high-performance computing (HPC) and AI data center services, as evidenced by the merger with CoreWeave, a specialized cloud provider for AI and HPC. The comparative analysis with data center REITs (Equinix, Digital Realty) and diversified cloud providers (Microsoft, Amazon, Google) highlights the evolving landscape and the convergence of these technologies. The litigation underscores the heightened scrutiny and disclosure requirements in complex, high-value mergers within rapidly developing technological industries.

Comparison to Industry Standards

• Core Scientific's valuation metrics (TEV/Adj. EBITDA) are compared against data center REITs: Equinix (18.6x CY2026E), Digital Realty (20.2x CY2026E), Keppel DC REIT (20.7x CY2026E), and Digital Core REIT (17.8x CY2026E). Core Scientific's consensus (as of July 3, 2025) was 19.8x for CY2026E, placing it within the range of these peers.
• CoreWeave's valuation metrics (TEV/Adj. EBITDA and TEV/Adj. EBIT) are compared against 'Pureplay Cloud' companies like Oracle (20.4x CY2026E EBITDA, 21.6x CY2027E EBIT) and Nebius (38.2x CY2026E EBITDA), and 'Diversified Cloud' companies such as Microsoft (18.4x CY2026E EBITDA, 19.5x CY2027E EBIT), Amazon (12.4x CY2026E EBITDA, 20.7x CY2027E EBIT), Google (11.1x CY2026E EBITDA, 13.6x CY2027E EBIT), and IBM (16.2x CY2026E EBITDA, 21.2x CY2027E EBIT). CoreWeave's consensus (as of July 3, 2025) was 12.0x for CY2026E EBITDA and 23.9x for CY2027E EBIT, showing it to be generally lower on EBITDA multiples than pureplay peers but competitive on EBIT multiples with diversified players.

Legal Proceedings

• Two purported stockholders of Core Scientific filed a lawsuit in the Connecticut Superior Court, Bridgeport Judicial District, Barcia et al. vs. Booth et al., Case No. FBT-CV-25-6151837S.
• One purported stockholder of Core Scientific filed a lawsuit in the New York Supreme Court, New York County, Kaufmann vs. Core Scientific, Inc. et al., Case No. 655996/2025.
• One purported stockholder of Core Scientific filed a lawsuit in the New York Supreme Court, New York County, Williams vs. Core Scientific, Inc. et al., Case No. 656010/2025.
• Purported stockholders of Core Scientific sent demand letters beginning August 22, 2025, alleging similar disclosure deficiencies.

Stakeholder Impact

• Shareholders: Directly impacted by the merger terms, voting process, and the outcome of the litigation challenging disclosures.
• Directors and Executive Officers: Named as defendants in the lawsuits, and their unvested equity awards are subject to vesting upon merger completion.
• CoreWeave: As the acquiring entity, its interests are tied to the successful and timely completion of the merger, free from legal impediments.
• Regulatory Authorities (SEC): Involved in the review and effectiveness of merger-related filings.

Next Steps

• Core Scientific stockholders will need to vote on the proposed transaction.
• Completion of the proposed transaction between Core Scientific and CoreWeave.

Key Dates

Recommendation

The filing indicates that Core Scientific is actively addressing shareholder lawsuits related to its merger with CoreWeave by providing supplemental disclosures. While this proactive measure aims to mitigate legal risks and avoid delays, the ongoing litigation introduces a degree of uncertainty to the transaction's timeline and terms. Investors should hold their positions to observe the resolution of these legal challenges and the ultimate completion of the merger, as these factors will significantly influence the company's future valuation and strategic direction.

Keywords

Core Scientific, CoreWeave, Merger, Acquisition, SEC Filing, Proxy Statement, Supplemental Disclosure, Litigation, Corporate Governance, Financial Analysis, Data Center, High-Performance Computing, Cryptocurrency Mining